RNA vaccines: a milestone toward a new era

Saito H. The RNA world ′hypothesis′. Nat Rev Mol Cell Biol 2022; 23(9): 582.

Fine JL, Pearlman JE. On the origin of life: an RNA-focused synthesis and narrative. RNA 2023; 29(8): 1085–98.

Panni S, Lovering RC, Porras P, Orchard S. Non-coding RNA regulatory networks. Biochim Biophys Acta Gene Regul Mech 2020; 1863(6): 194417.

Villarreal L, Witzany G. Self-empowerment of life through RNA networks, cells and viruses. F1000Research 2023; 12: 138.

Kirtipal N, Bharadwaj S, Kang SG. From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect Genet Evol 2020; 85: 104502.

El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, et al. Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. N Engl J Med 2021; 385(19): 1774–85.

Thomas SJ, Moreira ED Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine through 6 months. N Engl J Med 2021; 385(19): 1761–73.

Bartsch SM, Wedlock PT, O’Shea KJ, Cox SN, Strych U, Nuzzo JB, et al. Lives and costs saved by expanding and expediting coronavirus disease 2019 vaccination. J Infect Dis 2021; 224(6): 938–48.

Noor R. mRNA vaccines as an efficient approach for the rapid and robust induction of host immunity against SARS-CoV-2. SN Compr Clin Med 2022; 4(1): 88.

Santi Laurini G, Montanaro N, Broccoli M, Bonaldo G, Motola D. Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database. Vaccine 2023; 41(18): 2879–86.

Blumenthal KG, Greenhawt M, Phillips EJ, Agmon-Levin N, Gold-en DBK, Shaker M. An update in COVID-19 vaccine reactions in 2023: progress and understanding. J Allergy Clin Immunol Pract 2023; S2213–2198(23)00723–7.

Greenhawt M, Abrams EM, Shaker M, Chu DK, Khan D, Akin C, et al. The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international consensus approach. J Allergy Clin Immunol Pract 2021; 9(10): 3546–67.

Wong HL, Hu M, Zhou CK, Lloyd PC, Amend KL, Beachler DC, et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: A cohort study in claims da-tabases. Lancet 2022; 399(10342): 2191–9.

Świerkot J, Madej M, Szmyrka M, Korman L, Sokolik R, Andra-siak I, et al. The risk of autoimmunity development following mRNA COVID-19 vaccination. Viruses 2022; 14(12): 2655.

Janković S. Vaccination and autoimmune phenomena. Central Eur J Paed 2017; 13(1): 12–23.

Toussirot É, Bereau M. Vaccination and induction of autoim-mune diseases. Inflamm Allergy Drug Targets 2015; 14(2): 94–8.

Faust JS, Rasmussen SA, Jamieson DJ. Pregnancy should be a condition eligible for additional doses of COVID-19 messen-ger RNA vaccines. Am J Obstet Gynecol MFM 2023; 5(2): 100801.

Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Haas EJ, et al. Waning immunity after the BNT162b2 vaccine in Israel. N Engl J Med 2021; 385(24): e85.

Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature 2021; 592(7855): 616–22.

Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, et al. SARS-CoV-2 vaccine effectiveness against infection, symp-tomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2022; 22(1): 439.

The Nobel Prize. The Nobel Assembly at Karolinska Instituet: Press release [Internet]. Sweden: Nobel Prize Outreach; 2023 [cited 2023 Oct 12; accessed on 2023 Oct 23]. Available from: https://www.nobelprize.org/prizes/medicine/2023/press-rele

ase/

Liang X, Li D, Leng S, Zhu X. RNA-based pharmacotherapy for tumors: from bench to clinic and back. Biomed Pharma-coter 2020; 125: 109997.

Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, et al. Incorporation of pseudouridine into mRNA yields supe-rior nonimmunogenic vector with increased translational ca-pacity and biological stability. Mol Ther 2008; 16(11): 1833–40.

Morais P, Adachi H, Yu YT. The critical contribution of pseu-douridine to mRNA COVID-19 vaccines. Front Cell Dev Bi-ol 2021; 9: 789427.

Schoenmaker L, Witzigmann D, Kulkarni JA, Verbeke R, Kersten G, Jiskoot W, et al. mRNA-lipid nanoparticle COVID-19 vac-cines: structure and stability. Int J Pharm 2021; 601: 120586.

Ćirković MM. Natural and artificial: The cosmic Domain of Arnheim. In: Ćirković MM, editor. The astrobiological land-scape: philosophical foundations of the study of cosmic life. Cambridge: Cambridge University Press; 2012. p. 184–202.

Sadarangani M, Marchant A, Kollmann TR. Immunological mechanisms of vaccine-induced protection against COVID-19 in humans. Nat Rev Immunol 2021; 21(8): 475–84.

Matarazzo L, Bettencourt PJG. mRNA vaccines: a new oppor-tunity for malaria, tuberculosis and HIV. Front Immunol 2023; 14: 1172691.

Flemming A. mRNA vaccine shows promise in autoimmunity. Nat Rev Immunol 2021; 21(2): 72.

Lorentzen CL, Haanen JB, Met Ö, Svane IM. Clinical advances and ongoing trials of mRNA vaccines for cancer treatment. Lancet Oncol 2022; 23(10): e450–8. Erratum in: Lancet On-col 2022; 23(11): e492.

Lazarus JV, Wyka K, White TM, Picchio CA, Rabin K, Ratzan SC, et al. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Nat Commun 2022; 13(1): 3801.

Kafadar AH, Tekeli GG, Jones KA, Stephan B, Dening T. Deter-minants for COVID-19 vaccine hesitancy in the general popu-lation: a systematic review of reviews. Z Gesundh Wiss 2022; 19: 1–17.

Anderson KM, Creanza N. Internal and external factors affect-ing vaccination coverage: modeling the interactions between vaccine hesitancy, accessibility, and mandates. PLOS Glob Public Health 2023; 3(10): e0001186.

Olivera Mesa D, Winskill P, Ghani AC, Hauck K. The societal cost of vaccine refusal: a modelling study using measles vac-cination as a case study. Vaccine 2023; 41(28): 4129–37.

Coelho P, Foster K, Nedri M, Marques MD. Increased belief in vaccination conspiracy theories predicts increases in vaccina-tion hesitancy and powerlessness: results from a longitudinal study. Soc Sci Med 2022; 315: 115522.

Janković S. Anti-vaccine movements and scientific medicine. Biomedicinska istraživanja 2014; 5(1): 59–65. (Serbian)

Janković S. Childhood vaccination in the twenty-first century: parental concerns and challenges for physicians. Arh Farm 2019; 69: 452–68.

Banoun H. mRNA: vaccine or gene therapy? The safety regula-tory issues. Int J Mol Sci 2023; 24(13): 10514.